A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study
- 31 October 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 18 (4), 891-897
- https://doi.org/10.1016/0735-1097(91)90743-s
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Possible atrial proarrhythmic effects of class 1C antiarrhythmic drugsThe American Journal of Cardiology, 1990
- Different cardiodepressant potency of various calcium antagonists in human myocardiumThe American Journal of Cardiology, 1990
- Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutterThe American Journal of Cardiology, 1989
- Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutterThe American Journal of Cardiology, 1989
- Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter studyJournal of the American College of Cardiology, 1989
- Effects of hydrochlorothiazide and diltiazem on reflex vasoconstriction in hypertension.Hypertension, 1987
- Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1987
- Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.Circulation, 1983
- Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardiaThe American Journal of Cardiology, 1982
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981